Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orsana Italia is an innovative Italian healthcare company specializing in the development of specialized medical solutions for neonatology, pediatrics, ophthalmology, and dermatology. Headquartered in Naples, the company develops and markets a diverse portfolio of medical devices, nutraceutical supplements, and foods for special medical purposes (FSMP). Its core mission centers on improving patient care by providing high-quality, research-backed alternatives to standard pharmacological treatments. Notable products in its commercial lineup include Destrogel, a 40% dextrose gel for treating neonatal hypoglycemia, and Cicaben, a dermoprotective powder utilized for umbilical cord care and skin protection. Orsana Italia maintains research collaborations with major Italian medical institutions, such as the Fondazione Policlinico Gemelli, to validate the efficacy of its clinical formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orsana Italia.